Common Contracts

1 similar Exclusive Global License Agreement contracts

Contract
Exclusive Global License Agreement • December 10th, 2024

Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions